期刊文献+

创伤性脑损伤药物临床试验现状与研究趋向 被引量:5

原文传递
导出
摘要 创伤性脑损伤(traumaticbraininjury,TBI)病死率和致残率均位列创伤性疾病之首。近30多年来,许多研究者和药物研发机构投入巨大的精力和资金研究开发安全有效的TBI治疗药物,但迄今为止,全部Ⅲ期TBI药物临床试验均以阴性结果告终。为何TBI药物动物实验和临床前研究效果满意,但临床转化却都失败?这一问题引起广泛关注和高度重视。笔者分析TBI药物临床试验的现状,探讨TBI药物临床试验未来研究趋向。
出处 《中华创伤杂志》 CAS CSCD 北大核心 2016年第6期489-492,共4页 Chinese Journal of Trauma
  • 相关文献

参考文献19

  • 1Stein DG. Embracing failure: What the Phase III progesterone studies can teach about TBI clinical trials [ J ]. Brain Inj, 2015, 29 ( 11 ) : 1259-1272.
  • 2Edwards P, Arango M, Balica L, et al. Final results of MRC CRASH, a randomized placebo-controlled trial of intravenous corti- costeroid in adults with head injury-outcomes at 6 months [ J ]. Lancet, 2005, 365 (9475) : 1957-1959.
  • 3Temkin NR, Anderson GD, Winn HR, et al. Magnesium sulfate for neuroprotection after traumatic brain injury: a randomised controlled trial[J]. Lancet Neural, 2007, 6(1) :2938.
  • 4Skolnick BE, Maas AI, Narayan RK, et al. A clinical trial of progesterone for severe traumatic brain injury[ J]. N Engl J Med, 2014, 371(26) :2467-2476.
  • 5Wright DW, Yeatts SD, Silbergleit R, et al. Very early adminis- tration of progesterone for acute traumatic brain injury[ J]. N Engl J Med, 2014, 371 (26) :2457-2466.
  • 6肖国民.黄体酮对颅脑损伤神经保护研究现状[J].中华神经外科杂志,2014,30(5):530-533. 被引量:3
  • 7Loane DJ, Faden AI. Neuroproteetion for traumatic brain injury: translational challenges and emerging therapeutic strategies [ J ]. Trends Pharmacol Sci, 2010, 31 (12) :596-604.
  • 8Maas AI, Menon DK, Lingsma HF, et al. Re-orientation of clinical research in traumatic brain injury: report of an international workshop on comparative effectiveness research [ J ]. J Neurotranma, 2012, 29 ( 1 ) :32-46.
  • 9Lingsma HF, Roozenbeek B, Li B, et al. Large between center differences in outcome after moderate and severe traumatic brain injury in the IMPACT study[J]. Neurosurgery, 2011, 68(3): 601-607.
  • 10Saatman KE, Duhaime AC, Bullock R, et al. Workshop Scien- tific Team and Advisory Panel Members. Classification of trau- matic brain injury for targeted therapies [ J ]. J Neurotrauma, 2008, 25 (7) :719-738.

二级参考文献32

  • 1肖国民,危静,吴正虎,王卫民,姜启周,程军,陆峰,吴建跃,徐海松,方蓉.孕酮治疗急性重型颅脑损伤疗效和作用机制的临床研究[J].中华外科杂志,2007,45(2):106-108. 被引量:11
  • 2Bramlett HM, Dietrich WD. Progressive damage after brain and spinal cord injury: pathomechanisms and treatment strategies [ J]. Frog Brain Res,2007, 161:125- 141.
  • 3Stein DG. A clinical/translational perspective: can a develop- mental hormone play a role in the treatment of traumatic brain injury? [J]. Horm Behav, 2013, 63:291- 300.
  • 4Loane D J, Faden AI. Neuroprotection for traumatic brain injury: translational challenges and emerging therapeutic strategies [ J ]. Trends Pharmacol Sci, 2010, 31:596- 604.
  • 5Zafonte RD, Bagiella E, Ansel BM, et al. Effect of citicoline on functional and cognitive status among patients with traumatic brain injury: Citicoline Brain Injury Treatment Trial (COBRIT) [ J]. JAMA, 2012, 308:1993- 2000.
  • 6MeConeghy KW, Hatton J, Hughes L, et al. A review of neur- oproteetion pharmacology and therapies in patients with acute traumatic brain injury [J]. CNS Drugs, 2012, 26:613-636.
  • 7Vink R, Nimmo AJ. Multifunctional drugs for head injury" [ J ]. Neurotherapeutics, 2009, 6:28- 42.
  • 8Maas AI, Roozenbeek B, Manley GT. Clinical trials in traumatic brain injury: past experience and current developments [ J ]. Neurotherapeutics, 2010, 7 : 115- 126.
  • 9Mazzeo AT, Brophy GM, Gilman CB, et al. Safety and tolera- bility of cyclosporin a in severe traumatic brain injury patients: results from a prospective randomized trial [ J ]. J Neurotrauma, 2009, 26:2195- 2206.
  • 10Cimino M, Gelosa P, Gianella A, et al. Statins: multiple mec- hanisms of action in the ischemic brain [ J]. Neuroscientist, 2007, 13:208- 213.

共引文献2

同被引文献25

引证文献5

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部